September 27, 2022
SAN RAMON, Calif. — CooperVision’s MiSight 1 day contact lenses have garnered attention at the 2022 German Innovation Awards. The product received a special mention in “Excellence in Business to Consumer” in the Medical and Health category.
“This award represents a tremendous sense of achievement and means a lot to us,” said Johannes Zupfer, General Manager of Germany, Austria, and Switzerland at CooperVision. “On the one hand, it reflects our competence in terms of developing innovative contact lenses. But it also underscores our commitment to delivering solutions to our retail partners that will provide them with the best possible support in their day-to-day business.”
“Building a successful myopia management program is extremely important and the right thing to do, given the growing number children with myopia,”1 explained Zupfer. “Providing myopia control contact lenses early on, which both correct refractive error in age-appropriate* children and can help to reduce the rate of myopia progression,2 lowers the risk of eye disease,3 and can contribute to a child’s quality of life.4 That is and always has been our motivating force.”
The German Innovation Award is given for products, technologies, and services that break new ground in terms of innovation and for solutions that clearly stand out from conventional approaches. The distinction “Special Mention” is awarded to innovations distinguished for their well-conceived individual features, innovative approaches, or skillfully detailed solutions.
“Myopia progression doesn’t wait, so myopia management can’t,” said Elizabeth Lumb, BSc (Hons), MCOptom, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “We’re honored to have MiSight 1 day’s innovation celebrated, and above all, we’re grateful that this recognition can aid in spreading the word about myopia and its management.”
*U.S. Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1 Holden et al. Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016. 123(5):1036-1042
2 Chamberlain P et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci 2019;96:556-567.
3 Bullimore M. Myopia Control: Why each diopter matters. BCLA 2019 Poster.
4 Rah MJ, et al. Vision specific quality of life of pediatric contact lens wearers. Optom Vis Sci2010;87(8):560-6.